FindTrial
Sign In

Study held to see the effect of Arjuna- Manjistha lepa with madhu in Vyanga ( Melasma)

Clinical Evaluation of Arjuna- Manjistha lepa with madhu in Vyanga ( Melasma) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110780
Enrollment
40
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Sponsors

Priya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the ages of 16 to 50 years will be selected, regardless of their sex, caste, religion and occupation. Patients are willing to participate in the study and are prepared to provide their consent. Patients with the typical signs and symptoms of Melasma.

Exclusion criteria

Exclusion criteria: Patient who are below the age of 16 and over the age of 50. Patient having birth related hyperpigmentation. Vyanga during both gestation and lactation. Vyanga caused by Hormone replacement or OC Pills.

Design outcomes

Primary

MeasureTime frame
Arjuna-Manjistha lepa with madhu is effective in the management of Vyanga (Melasma)Timepoint: 30 days study with 2 follow ups ( 15th & 30th day)—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Garima Sharma

Uttaranchal Ayurvedic College and Hospital

drgarimaanuj17@gmail.com9760705010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026